Literature DB >> 20659672

Periocular rejuvenation: lower eyelid blepharoplasty with fat repositioning and the suborbicularis oculi fat.

Jonathan R Grant1, Keith A Laferriere.   

Abstract

Treatment of the aging lower eyelid is determined by the anatomic variables noted for each surgical candidate. Although surgeons have traditionally considered dermatochalasis, fat pseudoherniation, and eyelid position as the main treatment objectives in lower blepharoplasty, the vector of the infraorbital rim and the anterior plane of the cornea, tear trough, and aging in the midface also merit critical consideration. In this article, indications and technical aspects, the transconjunctival and external approaches, fat excision versus fat repositioning, and suborbicularis oculi fat lifting and fat transplantation are discussed and the authors' preference for the various methods of lower blepharoplasty is presented. Common adjunct procedures used to supplement lower blepharoplasty techniques and the role of injectable fillers in periocular rejuvenation are also mentioned. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20659672     DOI: 10.1016/j.fsc.2010.04.006

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN: 1064-7406            Impact factor:   1.918


  3 in total

Review 1.  Eyelid Malposition after Blepharoplasty: An Ounce of Prevention.

Authors:  Katherine J Williams; Richard C Allen
Journal:  Semin Plast Surg       Date:  2021-06-08       Impact factor: 2.314

Review 2.  Treatments of Infra-Orbital Dark Circles by Various Etiologies.

Authors:  Kui Young Park; Hyun Jung Kwon; Choon Shik Youn; Seong Jun Seo; Myeong Nam Kim
Journal:  Ann Dermatol       Date:  2018-08-28       Impact factor: 1.444

3.  Development and Validation of a Photonumeric Scale for Evaluation of Infraorbital Hollows.

Authors:  Lisa Donofrio; Jean Carruthers; Bhushan Hardas; Diane K Murphy; Derek Jones; Jonathan M Sykes; Alastair Carruthers; Lela Creutz; Ann Marx; Sara Dill
Journal:  Dermatol Surg       Date:  2016-10       Impact factor: 3.398

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.